<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/200C7CD6-42B7-4EBB-9BF0-5F3BFAACC139"><gtr:id>200C7CD6-42B7-4EBB-9BF0-5F3BFAACC139</gtr:id><gtr:firstName>Ashok</gtr:firstName><gtr:surname>Venkitaraman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12022%2F8"><gtr:id>0B82FFDB-9076-41B4-9F2E-6F001FE847BA</gtr:id><gtr:title>Therapeutic target discovery and validation programme &amp;amp; the systems microscopy initiative</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12022/8</gtr:grantReference><gtr:abstractText>The discovery and development of new drugs for human diseases is a major scientific priority worldwide, but the process is beset with challenges that make it difficult, expensive and protracted. Our work exploits advances in our understanding of the molecular circuits controlling normal and diseased cells to identify and validate new targets for the next generation of medicines. We are also developing new methods for microscopy to better understand the effect of new medicines on diseased cells.</gtr:abstractText><gtr:technicalSummary>There is a very high rate of attrition in the development of new classes of therapeutic agents that exploit our growing knowledge of the genetic basis of diseases like cancer, presenting a major impediment for academia and industry. Our ability to rapidly identify and validate of the best new therapeutic targets for drug development remains a a key challenge. To address this problem, we aim to build on the success of our recent work to develop novel approaches to systematically scrutinize cellular pathways altered in disease using large libraries encompassing diverse protein folds, and second, to extend using fragment-based and library-driven methods the discovery of chemical leads against novel molecular targets implicated in cellular regulation. In addition, our ongoing work to develop new approaches in light microscopy, such as hyper-dimensional imaging microscopy, to deconvolute complex cellular pathways will serve not only to advance understanding of disease-related derangements of these pathways, but also to validate diagnostic or therapeutic concepts for further development.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1457000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cambridge Science Festival 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>C815070E-9A63-4D02-BC84-633594B1B749</gtr:id><gtr:impact>Group members spoke about their research and coordinated activities for the public such as DNA extraction.

Increased awareness of cancer research and its importance.</gtr:impact><gtr:outcomeId>543e4b6144e7a6.48076089</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview on BBC Radio Cambridgeshire</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>08409B26-1543-403B-8421-3DB0DDA927FF</gtr:id><gtr:impact>Interview on local radion Drivetime programme to discuss cancer research and promote cambridge science festival activities

Increased awareness of research and attendance at festival event</gtr:impact><gtr:outcomeId>543e4c4c6a6237.42995797</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Festival Speaker Spotlight</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D8BB1E7B-4580-4711-AFB3-0A9BE6DFF7FF</gtr:id><gtr:impact>Interviewed for Cambridge Science Festival Speaker Spotlight

Increased awareness of cancer research and festival activities.</gtr:impact><gtr:outcomeId>543e4bd25c3199.20444292</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cam.ac.uk/science-festival/news-media/speaker-spotlights/speaker-spotlight-professor-ashok-venkitaraman</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D6EC3FD8-00C0-493A-9F0B-3E0F003B4C7D</gtr:id><gtr:title>Double Strain-Promoted Macrocyclization for the Rapid Selection of Cell-Active Stapled Peptides.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8586c6b180b864a824ed1eec5eb01a4"><gtr:id>a8586c6b180b864a824ed1eec5eb01a4</gtr:id><gtr:otherNames>Lau YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>56c71930991445.77820538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6227D6D-4E74-4180-9D5C-5C2DB6DBE175</gtr:id><gtr:title>Chromosome instability and carcinogenesis: insights from murine models of human pancreatic cancer associated with BRCA2 inactivation.</gtr:title><gtr:parentPublicationTitle>Molecular oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1333dc61a50bcdc0960fd1f4abc240f"><gtr:id>d1333dc61a50bcdc0960fd1f4abc240f</gtr:id><gtr:otherNames>Cassidy LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1574-7891</gtr:issn><gtr:outcomeId>5436a074935226.20290992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C56C593-13A5-4368-80BD-EF89E99271AD</gtr:id><gtr:title>Using a fragment-based approach to target protein-protein interactions.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584952b12d6156f6729a395528a9a0f6"><gtr:id>584952b12d6156f6729a395528a9a0f6</gtr:id><gtr:otherNames>Scott DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>pm_13318_28_23344974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C046140A-F7A3-45C9-9D9C-AFF1313FF896</gtr:id><gtr:title>Maximizing the biochemical resolving power of fluorescence microscopy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f542cf3e85d9fc356dcf95ba1bac77f"><gtr:id>4f542cf3e85d9fc356dcf95ba1bac77f</gtr:id><gtr:otherNames>Esposito A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5436a074bd82f0.77861645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D06347BF-169B-42E3-9FED-FC2EA303839F</gtr:id><gtr:title>Engineering Archeal Surrogate Systems for the Development of Protein-Protein Interaction Inhibitors against Human RAD51.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98f6ff9a11cf6a0dff5004c3ec23b7ed"><gtr:id>98f6ff9a11cf6a0dff5004c3ec23b7ed</gtr:id><gtr:otherNames>Moschetti T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>5806228001bae5.38468821</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>982A2C09-BEF6-4806-9305-4401B73EF4D8</gtr:id><gtr:title>High content screening of diverse compound libraries identifies potent modulators of tubulin dynamics.</gtr:title><gtr:parentPublicationTitle>ACS medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f5b243c4d6b98f63194d44a82af0669"><gtr:id>0f5b243c4d6b98f63194d44a82af0669</gtr:id><gtr:otherNames>Laraia L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1948-5875</gtr:issn><gtr:outcomeId>54369fff59f1d9.42388833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>390AAABB-0D43-49BB-86CA-B7D1E7449CC6</gtr:id><gtr:title>Fast and simple spectral FLIM for biochemical and medical imaging.</gtr:title><gtr:parentPublicationTitle>Optics express</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7112117de6a6278abb94866d1e21364"><gtr:id>e7112117de6a6278abb94866d1e21364</gtr:id><gtr:otherNames>Popleteeva M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1094-4087</gtr:issn><gtr:outcomeId>560cf485695426.64147424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>180204F1-B6D3-46FF-9368-EAF9D076C0F1</gtr:id><gtr:title>Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/405661fdcf6221fcaf0188903b88709e"><gtr:id>405661fdcf6221fcaf0188903b88709e</gtr:id><gtr:otherNames>Piccirillo SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>560cf4861241b4.30809774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D9895DD-6215-4446-BA60-0DC7207DA317</gtr:id><gtr:title>RNA Processing and Genome Stability: Cause and Consequence.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>56d6b2a41f6f91.00301229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE3898CB-AC69-497F-83C7-1B6E3A2D7B54</gtr:id><gtr:title>Investigating peptide sequence variations for 'double-click' stapled p53 peptides.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8586c6b180b864a824ed1eec5eb01a4"><gtr:id>a8586c6b180b864a824ed1eec5eb01a4</gtr:id><gtr:otherNames>Lau YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>5436a0733da501.21421209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCFCF02C-4777-430E-9122-8ABA0D5ED345</gtr:id><gtr:title>Modulating Protein-Protein Interactions of the Mitotic Polo-like Kinases to Target Mutant KRAS.</gtr:title><gtr:parentPublicationTitle>Cell chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/187f9a328dc6313ad6bb6511540f482a"><gtr:id>187f9a328dc6313ad6bb6511540f482a</gtr:id><gtr:otherNames>Narvaez AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2451-9448</gtr:issn><gtr:outcomeId>5a2fd5b2b300e5.40269283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8495F224-0362-47CD-A2DC-F9A1B0E51B0C</gtr:id><gtr:title>Linear aliphatic dialkynes as alternative linkers for double-click stapling of p53-derived peptides.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8586c6b180b864a824ed1eec5eb01a4"><gtr:id>a8586c6b180b864a824ed1eec5eb01a4</gtr:id><gtr:otherNames>Lau YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>545e5a98179cc7.81091990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CA584D0-A528-4511-B084-2146E32F88E9</gtr:id><gtr:title>A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0f8965e8e8465c924c0a035380d968b"><gtr:id>e0f8965e8e8465c924c0a035380d968b</gtr:id><gtr:otherNames>Jeyasekharan AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_13318_28_24013206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8BCDFAC-410F-435C-A121-CDC180EFE7B5</gtr:id><gtr:title>Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5' splice site strength.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>560cf4852d82c6.89842347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>997A5878-3CF2-4ECB-BCE9-76707955E56D</gtr:id><gtr:title>Diversity-oriented synthesis as a tool for identifying new modulators of mitosis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5966b8b69ea8c08c65551eb5584b90da"><gtr:id>5966b8b69ea8c08c65551eb5584b90da</gtr:id><gtr:otherNames>Ibbeson BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5436a0745dc985.18189042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>799140A2-0F06-49BA-B0A9-C28B228D033F</gtr:id><gtr:title>Single-molecule localization microscopy reveals molecular transactions during RAD51 filament assembly at cellular DNA damage sites.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab21d44b78fe23719d03571b6a3577e3"><gtr:id>ab21d44b78fe23719d03571b6a3577e3</gtr:id><gtr:otherNames>Haas KT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5a8af2b41eacc3.79498468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A63D4E23-3881-4E72-A188-A0B959CDD84F</gtr:id><gtr:title>Cancer suppression by the chromosome custodians, BRCA1 and BRCA2.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5436a0736524f5.66150703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28B73ABA-FE3D-4FA4-B4C4-7F27ED36AA30</gtr:id><gtr:title>Human inositol polyphosphate multikinase regulates transcript-selective nuclear mRNA export to preserve genome integrity.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_13318_28_24074953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>873E0603-5EF6-47E1-A1E0-0A159B359857</gtr:id><gtr:title>Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f5b243c4d6b98f63194d44a82af0669"><gtr:id>0f5b243c4d6b98f63194d44a82af0669</gtr:id><gtr:otherNames>Laraia L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>560cf485d48c42.83271908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32D00989-7B79-4D48-89E8-3253A9AF326E</gtr:id><gtr:title>Specific inhibition of CK2a from an anchor outside the active site.</gtr:title><gtr:parentPublicationTitle>Chemical science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bd1718b7076fd687beb1551670bba26"><gtr:id>3bd1718b7076fd687beb1551670bba26</gtr:id><gtr:otherNames>Brear P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-6520</gtr:issn><gtr:outcomeId>585d36891a31c1.23428920</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>690A0A86-B22C-41EB-AA1D-21C1E2B7D85C</gtr:id><gtr:title>Oncogenic KRAS triggers MAPK-dependent errors in mitosis and MYC-dependent sensitivity to anti-mitotic agents.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b77196dcbdac386045a7b78c93cc1468"><gtr:id>b77196dcbdac386045a7b78c93cc1468</gtr:id><gtr:otherNames>Perera D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d69859475d9.84005924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C655C31-6FEA-4D30-B232-0DBCC3B4A28E</gtr:id><gtr:title>Homeostatic control of polo-like kinase-1 engenders non-genetic heterogeneity in G2 checkpoint fidelity and timing.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24ec375abd205ba8e96b7e4e07a57e2b"><gtr:id>24ec375abd205ba8e96b7e4e07a57e2b</gtr:id><gtr:otherNames>Liang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5436a0730c63b3.24331542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCE78C5D-6B3D-432F-953F-598D4A142A9C</gtr:id><gtr:title>High-resolution structure of the presynaptic RAD51 filament on single-stranded DNA by electron cryo-microscopy.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba4097716d2c886a85ad04e75c4aa8d2"><gtr:id>ba4097716d2c886a85ad04e75c4aa8d2</gtr:id><gtr:otherNames>Short JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5806228023f215.45405734</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D34D978-A1EC-47A0-BC07-AF4F1B4C83A7</gtr:id><gtr:title>p53 shapes genome-wide and cell type-specific changes in microRNA expression during the human DNA damage response.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7de3df12752ce5f2ad67ba8b804a0bc"><gtr:id>f7de3df12752ce5f2ad67ba8b804a0bc</gtr:id><gtr:otherNames>Hattori H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>545e5a97e8b238.79182008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56A03BDE-E6DE-42DE-BCB5-484B9E7187BA</gtr:id><gtr:title>Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase-TPX2 protein-protein interaction.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74caa858e1c4622a8245ad51cfc3acbe"><gtr:id>74caa858e1c4622a8245ad51cfc3acbe</gtr:id><gtr:otherNames>Cole DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>5a35ad2e121b39.47480441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F5B3798-CB46-4D54-9F3D-D0652D791924</gtr:id><gtr:title>Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9984bc41af77236e9cd269aa01cfc43"><gtr:id>e9984bc41af77236e9cd269aa01cfc43</gtr:id><gtr:otherNames>Janecek M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d54a14709f0.00635356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2ACBCC61-E27F-49FA-8134-CE2D3A08F8B3</gtr:id><gtr:title>Small-molecule inhibitors that target protein-protein interactions in the RAD51 family of recombinases.</gtr:title><gtr:parentPublicationTitle>ChemMedChem</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584952b12d6156f6729a395528a9a0f6"><gtr:id>584952b12d6156f6729a395528a9a0f6</gtr:id><gtr:otherNames>Scott DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1860-7179</gtr:issn><gtr:outcomeId>56e158a951dd79.34984658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5ADDC73B-69C9-4043-AE6F-A6221CDEE913</gtr:id><gtr:title>Selective nuclear export of specific classes of mRNA from mammalian nuclei is promoted by GANP.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5436a074086e53.17611449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D91B93E0-8C71-4131-98F2-CA9CC1400348</gtr:id><gtr:title>Micro(mi) RNA-34a targets protein phosphatase (PP)1? to regulate DNA damage tolerance.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc329042393bda9d8373ce4d6b137310"><gtr:id>cc329042393bda9d8373ce4d6b137310</gtr:id><gtr:otherNames>Takeda Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>560cf485a20e24.00359131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38045527-3C06-4FC8-BDE2-7E933FCB90C0</gtr:id><gtr:title>A-type lamins maintain the positional stability of DNA damage repair foci in mammalian nuclei.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1700422215cd472efef9d11f67e1c5b"><gtr:id>d1700422215cd472efef9d11f67e1c5b</gtr:id><gtr:otherNames>Mahen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13318_28_23658700</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12022/8</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>